Answers are grounded in this paper and cite their sources.
The article presents current data on prevention of fungal infection in children in the context of hematopoietic stem cell transplantation (HSCT) and the place of voriconazole in it. Own experience shows the results of treatment of patients with malignant and non-malignant diseases in the Department of bone marrow transplantation of the Russian Children's Clinical Hospital. A total of 161 patients aged 4 to 18 years who received allogeneic or autologic HSCT for the period from 2012 to 2014 was examined. It has been shown that the application of voriconazole prophylaxis reduces the incidence of fungal infection development, particularly in conditions of not always favorable epidemiological situation. The characteristics of preventive treatment of this group of diseases in children were analyzed.
No takes yet. Share an insight, caveat, or question.
Konstantinova et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: